Effects of unsaturated side-chain analogs of tetrahydrocannabinol on cytochromes P450

被引:4
作者
Bornheim, LM
机构
[1] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA
关键词
cytochrome P450; P450; 3A; P4502C; cannabinoids; mechanism-based inactivation; tetrahydrocannabinol;
D O I
10.1016/S0006-2952(00)00431-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The ability of unsaturated side-chain analogs of Δ8- tetrahydrocannabinol (THC) to selectively inactivate mouse hepatic cytochromes P450 3A11 and 2C29 was examined. THC side-chain analogs were preincubated with mouse hepatic microsomes and NADPH for various times before dilution and determination of Δ9-THC metabolism specific for P450s 3A11 and 2C29. THC-enyl analogs had little or no effect on P450 3A11 but inactivated P450 2C29 in a time-dependent manner, with approximately 50% inactivation observed after a 30-min preincubation. THC-ynyl analogs were less selective in their P450 inactivation but appeared to be more effective than their corresponding enyl analogs. THC-ynyl analogs inactivated P450s 3A11 and 2C29 in a time-dependent manner and could inactive 40-80% of their activities after a 30-min preincubation. The THC-ynyl analogs were nearly as effective as cannabidiol, a well-characterized inactivator of these mouse P450s. Despite their ability to inactivate P450 in vitro, neither the THC-enyl nor the THC-ynyl analogs were very effective after in vivo administration. Unsaturated side-chain THC analogs may be useful in the development of specific P450 inactivators. (C) 2000 Elsevier Science Inc.
引用
收藏
页码:955 / 961
页数:7
相关论文
共 35 条
[21]  
Martin BR, 1999, J PHARMACOL EXP THER, V290, P1065
[22]   CONSTRUCTION OF A BIOCHEMO-MECHANICAL SYSTEM USING ENZYME-LOADED POLYELECTROLYTE GELS [J].
MATSUDA, K ;
ORII, H ;
HIRATA, M ;
KOKUFUTA, E .
POLYMER GELS AND NETWORKS, 1994, 2 (3-4) :299-305
[23]  
NAGAHISA A, 1983, J BIOL CHEM, V258, P6721
[24]  
NEWTON DJ, 1995, DRUG METAB DISPOS, V23, P154
[25]  
Ortiz de Montellano P.R, 1980, J BIOL CHEM, V255, P5578
[26]   Pharmacophoric requirements for cannabinoid side chains:: Multiple bond and C1′-substituted Δ8-tetrahydrocannabinols [J].
Papahatjis, DP ;
Kourouli, T ;
Abadji, V ;
Goutopoulos, A ;
Makriyannis, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (07) :1195-1200
[27]   Pharmacology of cannabinoid CB1 and CB2 receptors [J].
Pertwee, RG .
PHARMACOLOGY & THERAPEUTICS, 1997, 74 (02) :129-180
[28]  
RAZDAN RK, 1976, J MED CHEM, V19, P1328, DOI 10.1021/jm00233a014
[29]   UNIVERSAL APPROACH TO THE EXPRESSION OF HUMAN AND RABBIT CYTOCHROME P450S OF THE 2C SUBFAMILY IN ESCHERICHIA-COLI [J].
RICHARDSON, TH ;
JUNG, F ;
GRIFFIN, KJ ;
WESTER, M ;
RAUCY, JL ;
KEMPER, B ;
BORNHEIM, LM ;
HASSETT, C ;
OMIECINSKI, CJ ;
JOHNSON, EF .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1995, 323 (01) :87-96
[30]   A NOVEL CLASS OF POTENT TETRAHYDROCANNABINOLS (THCS) - 2'-YNE-DELTA(8)-THCS AND DELTA(9)-THCS [J].
RYAN, W ;
SINGER, M ;
RAZDAN, RK ;
COMPTON, DR ;
MARTIN, BR .
LIFE SCIENCES, 1995, 56 (23-24) :2013-2020